igf-1 semaglutide DES 1mg IGF-1 LR3 + MASS Cycle

Plan your dosing schedule accordingly to use the full vial before the BUD expires

Life in these arid environments is feast or famine

Acronyms A1C - Hemoglobin A1C ADA - American Diabetes Association CVD - Cardiovascular disease DM - Diabetes mellitus FBS - Fasting blood sugar GFR - Glomerular filtration rate GI - Gastrointestinal GLP-1 - Glucagon-like peptide-1 OSA - Obstructive sleep apnea RCT - Randomized controlled trial T2DM - Type 2 diabetes mellitus Thyroid C-cell tumor = Thyroid medullary tumor DRUGS IN CLASS Dual GLP-1 and GIP agonists Tirzepatide (Mounjaro) - marketed for diabetes Tirzepatide (Zepbound) - marketed for weight loss MECHANISM OF ACTION GLP-1 and GIP GLP-1 stands for "glucagon-like peptide-1," and GIP stands for "glucose-dependent insulinotropic polypeptide." GIP is also sometimes referred to as "gastric inhibitory polypeptide." GLP-1 and GIP are hormones secreted by specialized cells in the small intestine in response to food consumption

November 8, 2023 (obesity, as Zepbound) Starting switch dose / 2.5 mg tirzepatide weekly, regardless of prior semaglutide dose Typical washout / None strictly required

Strut starts from population-average titration and adjusts based on subjective tolerability over the first 812 weeks

SynergyRx Compounded Semaglutide offers results that are not only noticeable but also steady, realistic, and backed by the same scientific foundation as traditional GLP-1 medications